Readership
Biomedical Researchers, Cardiologists, Clinicians, Family Practice Physicians, General Practitioners, Hematologists, HyperTension Specialists, Molecular Biologists, Physician Assistants, Physicians, Physicians - Medicine, Physiologists, Public Health Professionals, Vascular Medicine Specialists
Scope
Cardiovascular disease causes one-third of deaths worldwide and represents an urgent threat to global health. The scientific, clinical, pharmacological and public health communities have coordinated efforts to prevent, diagnose, treat and cure cardiovascular disease. This important mission depends upon advances in our understanding of the aetiology, molecular mechanisms and socioeconomic factors driving and affecting the disease.
Nature Cardiovascular Research aims to serve this multidisciplinary community by providing a unifying publishing platform that will champion and disseminate original and important advances in basic, translational, clinical and public health research in cardiovascular biology and haematology. The journal will also serve as a forum for raising challenging questions and exchanging new concepts and ideas, which will inspire and stimulate future research directions.
Topics covered in the journal include: Basic cardiovascular and haematology research (Development and angiogenesis, Haematopoiesis, Stem cell biology, Molecular and cellular biology, Physiology, Metabolism, Genetics and genomics, Systems biology and ‘omics approaches, Regenerative medicine, including tissue bioengineering, Inter-organ communication, Cardiovascular and blood diseases): Cardiac conduction and arrhythmia (Cardiomyopathy, Heart failure, Valvular disease, Congenital cardiovascular and blood diseases, Cardiovascular effects of inflammation, IIschaemic heart disease, Vascular and lymphatic disorders, Hypertension, Atherosclerosis, Stroke, Thrombosis and haemostasis, Bleeding disorders, Anaemia): Translational and clinical research (Prognostic and diagnostic tools and imaging techniques,
Artificial intelligence and technology, New techniques and resources, Drug targeting, Treatments of cardiovascular or blood diseases, Clinical trials and observations): Cardiovascular and blood health sciences (Public and global health, Public policy).